spacer
home > pmps > winter 2017 > working together
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Working Together

If the pharmaceutical supply chain was a living, breathing creature, it would probably be the microscopic water flea. Daphnia pulex was the first crustacean to have its genome sequenced, and results showed that it has 31,000 genes – 25% more than us humans. Just like the genetic complexity of the water flea was a challenge for scientists, the sophisticated pharma supply chain is now changing the way the industry operates.

The rise of emerging markets and the different geographic standards used around the world are additional challenges that manufacturers need to address. As always in the pharma sector, the complex regulatory landscape has a significant impact on companies. This includes widely recognised guidelines such as those from the FDA and their European counterparts, as well as client standards and environmental legislation. All of these factors are contributing to making the supply chain nearly impossible to navigate.

Current Situation

As new markets and technologies emerge in the pharma field, manufacturers are starting to feel the pressure of working with a higher number of suppliers, partners and distributors. They often produce drugs for pharmacies or specific patients, rather than wholesale – this means that the industry is starting to be driven by demand rather than forecast. The medicines themselves are becoming progressively complex and bespoke, meaning that the production of mini batches or personalised medicine is another rising trend.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Darren Halford is Sales Director at obsolete components supplier EU Automation. Previously, he has worked as a recruitment consultant, recommending new employment opportunities to senior construction professionals. Darren oversees all sales and service operations and has been with the company since its inception in May 2009.
spacer
Darren Halford
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Destiny Pharma appoints MedPharm to develop new XF-platform drug formulations

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel antimicrobial drugs, is pleased to announce that it has appointed MedPharm as its expert partner to develop new topical formulations of the Company’s novel XF-platform compounds. These new treatments for dermal and ocular infections are part of its second clinical programme to address the global problem of anti-microbial resistance (AMR). MedPharm is a world leading contract provider of topical and transdermal product design and formulation development services using sophisticated in vitro models to de-risk development programmes.
More info >>

White Papers

eSource: Reducing Site Workload for Better, Faster, Safer Clinical Trials

Clinical Ink

Unlike traditional electronic data capture (EDC), SureSource, Clinical Ink’s eSource platform, was designed from the beginning to minimize clinical trial complexity for site users. A Site Impact Survey provides scientific evidence regarding the impact of SureSource from 517 site users. Results confirm it significantly reduces workload, lessens queries, and improves data quality compared to paper and EDC. In this white paper, we quantitatively evaluate survey outcomes, provide qualitative feedback from survey respondents, and highlight the observed benefits of SureSource for transforming clinical research.
More info >>

 
Industry Events

PDA Europe Annual Meeting 2019

24 June 2019, Hilton Amsterdam

Featuring updates from international regulatory agencies as well as industry, this promises to become another highlight in the 2019 event calendar and is a meeting not to be missed!
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement